Canada markets close in 2 hours 10 minutes

Enliven Therapeutics, Inc. (ELVN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
23.20-0.60 (-2.54%)
As of 01:50PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.12B
Enterprise Value 799.69M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.53
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 317.93%
S&P500 52-Week Change 326.36%
52 Week High 326.00
52 Week Low 39.80
50-Day Moving Average 318.72
200-Day Moving Average 315.33

Share Statistics

Avg Vol (3 month) 3307.49k
Avg Vol (10 day) 3367.87k
Shares Outstanding 547.04M
Implied Shares Outstanding 647.41M
Float 818.12M
% Held by Insiders 16.78%
% Held by Institutions 192.73%
Shares Short (Apr 30, 2024) 44.73M
Short Ratio (Apr 30, 2024) 49.27
Short % of Float (Apr 30, 2024) 425.09%
Short % of Shares Outstanding (Apr 30, 2024) 410.07%
Shares Short (prior month Mar 28, 2024) 44.23M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-17.52%
Return on Equity (ttm)-26.14%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -90.19M
Net Income Avi to Common (ttm)-79.6M
Diluted EPS (ttm)-1.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)320.5M
Total Cash Per Share (mrq)6.81
Total Debt (mrq)252k
Total Debt/Equity (mrq)0.08%
Current Ratio (mrq)13.47
Book Value Per Share (mrq)6.79

Cash Flow Statement

Operating Cash Flow (ttm)-63.79M
Levered Free Cash Flow (ttm)-36.55M